Systematic Review with Network Meta-Analysis: Comparative Efficacy of Biologics in the Treatment of Moderately to Severely Active Ulcerative Colitis-Reference-Cited by-同舟云学术

Systematic Review with Network Meta-Analysis: Comparative Efficacy of Biologics in the Treatment of Moderately to Severely Active Ulcerative Colitis

Published:2016-10-24 Issue:10 Volume:11 Page:e0165435
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Vickers Adrian D.,Ainsworth Claire,Mody Reema,Bergman Annika,Ling Caroline S.,Medjedovic Jasmina,Smyth Michael

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference56 articles.

1. Crohn’s and Colitis UK. Ulcerative colitis Ed 8a—November 2013. Available: https://www.crohnsandcolitis.org.uk/about-inflammatory-bowel-disease/publications/ulcerative-colitis. Accessed 26 May 2016.

2. National Institutes of Health. Ulcerative colitis. June 2010. Available: http://www.nlm.nih.gov/medlineplus/ulcerativecolitis.html. Accessed 4 Sep 2012.

3. National Institute for Health and Care Excellence. Ulcerative colitis: management in adults, children and young people. June 2013. Available: https://www.nice.org.uk/guidance/cg166/chapter/introduction. Accessed 9 Apr 2015.

4. Recent trends in the prevalence of Crohn’s disease and ulcerative colitis in a commercially insured US population;MD Kappelman;Dig Dis Sci,2013

5. The impact of ulcerative colitis on patients’ lives compared to other chronic diseases: a patient survey;DT Rubin;Dig Dis Sci,2010

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Old and New Biologics and Small Molecules in Inflammatory Bowel Disease: Anti Integrins;The Korean Journal of Gastroenterology;2024-08-25

2. Comparative Efficacy and Safety of Upadacitinib vs. Vedolizumab, Ustekinumab, and Tofacitinib After Induction and Maintenance for Ulcerative Colitis: Three Matching-Adjusted Indirect Comparisons;Advances in Therapy;2024-08-10

3. Efficacy and Safety of Infliximab Versus Adalimumab in Adult Subjects With Moderate to Severe Ulcerative Colitis: A Systematic Review and Meta-Analysis;Cureus;2024-06-02

4. Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA;Pharmaceutics;2024-05-08

5. Assessing the economics of biologic and small molecule therapies for the treatment of moderate to severe ulcerative colitis in Japan: a cost per responder analysis of upadacitinib;Journal of Medical Economics;2024-04-05